Expansion and Activation of CD103+ Dendritic Cell Progenitors at the Tumor Site Enhances Tumor Responses to Therapeutic PD-L1 and BRAF Inhibition
Icahn School of Medicine at Mount Sinai · Stanford University · +5 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
1,161
total citations
- FWCI
- 38.61
- Percentile
- 100%
- References
- 46
Citations per year
Authors
22Topics & keywords
Topics
Keywords
- Biology
- Cancer research
- Progenitor cell
- Progenitor
- Tumor cells
- Cell biology
- Stem cell
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.
Funding
- CRCancer Research Institute
- APAssociation pour la Recherche sur le Cancer
- MOMinistry of Education, Culture, Sports, Science and Technology
- NINational Institutes of HealthAwards: R01AI104848, R01 CA173861, U01AI095611, R01CA190400, R01 CA154947A
- JSJapan Society for the Promotion of ScienceAward: 26461438